Market Pulse
Structured intelligence on corporate strategy, market moves, and industry signals.
Each entry is a briefing, not a headline: event summary, strategic context, and what to watch next.
A Company Pulse is our reading of what a company says in its own press release, with the questions we would want answered. It is not verified reporting and it is not an endorsement. Pulses are made from press releases we collect from several sources, including Wire. Nobody can pay for a Pulse.
Revenue declined 14.0% year-over-year to $191.3 million on a pro forma basis
Read full analysis →
FocalTherics reported $13.2M in Q2 revenue, up 39% YoY, driven by 47% growth in U.S. procedures.
Read full analysis →
Credit Acceptance ranked 11th in PEOPLE’s 2026 100 Companies That Care, up from 44th in 2025.
Read full analysis →
Phase 2 monotherapy trial of FG-3246 for mCRPC on track for interim analysis in 4Q 2026.
Read full analysis →
Gossamer Bio reacquired worldwide rights to seralutinib from Chiesi for a $5 million one-time payment, terminating their prior collaboration agreement.
Read full analysis →
Soluna reported Q2 2026 revenue of $15.1 million, up 145% year-over-year and 60% sequentially.
Read full analysis →
Micron Ventures launched its third and largest fund, the $250 million Paradigm Fund, to invest in AI technology startups.
Read full analysis →
Daré Bioscience launched Flora Sync LF5, its first directly commercialized product, generating revenue starting July 2026.
Read full analysis →
Completed enrollment in ALIGN-ACS pilot study ahead of schedule, with data analysis underway for presentation at TCT 2026.
Read full analysis →
$60.1M net loss in Q2 2026, with $20.1M cash used in operations
Read full analysis →
Aktis presented first-in-human imaging data for AKY-2519 at ASCO, showing robust tumor uptake and limited normal tissue exposure.
Read full analysis →
NextNRG reported Q2 2026 revenue of $27.7M, up 41% YoY, driven by mobile fueling expansion.
Read full analysis →
Mobilicom reported $1.7 million in first-half revenue, up 19% year-over-year, driven by U.S. DoW Program of Record deliveries shifting to a monthly cadence.
Read full analysis →
Applied Materials reported Q3 2026 revenue of $9.12 billion, up 25% YoY.
Read full analysis →
$26.2M in Q2 2026 U.S. neffy revenue, up from $12.8M in Q2 2025; total market share hits 5%, doubling year-over-year.
Read full analysis →
Zentalis Pharmaceuticals (Nasdaq: ZNTL) initiated a proposed underwritten public offering of common stock and pre-funded warrants on August 13, 2026
Read full analysis →
NYSE Regulation has initiated delisting proceedings for SES AI Corporation's warrants (ticker: SES WS) due to abnormally low selling prices.
Read full analysis →
RFA Financial sold industrial properties in Saskatoon and Winnipeg for $93.8M, with additional dispositions pending.
Read full analysis →
Mountain Province Diamonds reported a net loss of $120.6 million for Q2 2026, despite record production of 2.015 million carats.
Read full analysis →
Lightmatter launched the Open Silicon Photonics for AI Systems initiative as an official workstream within OCP, with 19 member companies.
Read full analysis →
